Sandoz Everolimus 2.5 mg (Everolimus TABLET) 2.5 MG

SANDOZ EVEROLIMUS 2.5 MG tablets are an oral medication used to manage specific medical conditions. This prescription drug is designed to support treatment plans as directed by healthcare professionals.

Strength

2.5 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Everolimus is primarily used to help manage certain conditions related to organ transplantation and specific types of tumors. It works by affecting the immune system and inhibiting cell growth. People often ask, 'What is everolimus used for?' and the answer typically involves its role in preventing organ rejection and supporting cancer treatment protocols.

Side Effects

Common effects of everolimus may include fatigue, nausea, and mild skin reactions. Some users also report changes in appetite or digestive issues. These effects can vary widely depending on individual health factors and the specific condition being treated.

Precautions & Warnings

Everolimus should be handled with care, especially regarding potential interactions with other medications. It is important to follow the advice of a healthcare provider when starting or adjusting the dosage. Regular monitoring may be necessary to ensure safety and effectiveness.

Avoid Interactions

Everolimus can interact with a variety of substances, including certain antifungal medications, antibiotics, and drugs that affect liver enzymes. Alcohol and other immunosuppressants may also influence its effects. Always consult a healthcare professional before combining everolimus with other treatments.

Frequently Asked Questions

Everolimus is used to help prevent organ rejection after transplants and to support treatment for certain types of tumors.

Store everolimus tablets at room temperature, away from moisture and direct sunlight. Keep them in their original packaging.

Everolimus can be taken with or without food, but it is important to follow the specific instructions provided by your healthcare professional.

Common side effects may include fatigue, nausea, and mild skin reactions. Always consult a healthcare provider for personalized advice.

Yes, everolimus is available in various strengths, including 2.5 mg tablets. The appropriate strength depends on the specific treatment plan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.